Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

BACKGROUND: A serogroup A meningococcal polysaccharide–tetanus toxoid conjugate vaccine (PsA–TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African meningitis belt. We studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Daugla, DM, Gami, JP, Gamougam, K, Naibei, N, Mbainadji, L, Narbé, M, Toralta, J, Kodbesse, B, Ngadoua, C, Coldiron, ME, Fermon, F, Page, A-L, Djingarey, MH, Hugonnet, S, Harrison, OB, Rebbetts, LS, Tekletsion, Y, Watkins, ER, Hill, D, Caugant, DA, Chandramohan, D, Hassan-King, M, Manigart, O, Nascimento, M, Woukeu, A, Trotter, C, Stuart, JM, Maiden, MCJ, Greenwood, BM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898950/
https://www.ncbi.nlm.nih.gov/pubmed/24035220
http://dx.doi.org/10.1016/S0140-6736(13)61612-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898950/
https://www.ncbi.nlm.nih.gov/pubmed/24035220
http://dx.doi.org/10.1016/S0140-6736(13)61612-8

Ejemplares similares